US SEC Filings Daily Market Digest — June 11, 2026

11-06-2026

Verano Holdings Corp. completed a 1-for-5 reverse stock split effective June 11, 2026, and reduced authorized shares from 5,000,000,000 to 1,000,000,000 to position for a potential U.S. stock exchange listing. The company's outstanding shares dropped from 367,690,781 to approximately 73,918,135 post-split, and the stock continues to trade on Cboe Canada and OTCQX with a temporary symbol change for 20 business days. The reverse split follows its November 2025 redomiciling to Nevada and aims to attract institutional interest, though it does not guarantee an uplisting or improved liquidity.

• · The company operates in 13 U.S. states with 14 production facilities and over 1.1 million square feet of cultivation capacity.
• · The redomiciling to Nevada occurred in November 2025.
• · No fractional shares will be issued; cash payments will be made to stockholders entitled to fractional shares based on the closing price on Cboe Canada on June 10, 2026, adjusted for the split.
• · The company had 367,690,781 shares issued before the split, resulting in approximately 73,918,135 shares post-split.
• · The OTCQX ticker will be VRNOD for 20 business days then revert to VRNO.
• · The Normal Course Issuer Bid amended to allow up to 3,643,858 common shares to be repurchased.
• · Exercise or conversion prices and underlying shares of stock options, RSUs, and other convertible securities were proportionately adjusted.

11-06-2026

LiveRamp has become the first independent ad tech company to partner with OpenAI as a conversion API partner, enabling brands to pipe transaction data into OpenAI's ChatGPT ads to measure real-world sales impact. The partnership is initially U.S.-only with Europe expected to follow, and the first advertiser is expected to go live this week. However, LiveRamp's pending acquisition by Publicis (expected to close by year end 2026) raises concerns about its future neutrality as an independent data partner, which could affect advertiser trust and the partnership's long-term scalability.

• · OpenAI's ad buying models moved from CPM to CPC to CPA in roughly two months, reflecting advertiser pressure for accountability.
• · LiveRamp will operate as a standalone company under Publicis, with neutrality explicitly committed in the deal announcement.
• · The partnership is expected to expand to clicks and additional identifiers in the coming months, with clean room integration as a potential next step.
• · TikTok took about four years to bring in third-party measurement; OpenAI is doing it in four months.

11-06-2026

On June 11, 2026, Philip Morris International Inc. announced that its Board of Directors declared a regular quarterly dividend of $1.47 per common share. This disclosure was made via a press release furnished under Regulation FD. No other financial results or operational updates were provided in this filing.

• · The dividend declaration was made by the Board of Directors on June 11, 2026.
• · The press release is attached as Exhibit 99.1 to the Form 8-K.
• · The filing is furnished under Item 7.01 (Regulation FD Disclosure) and is not deemed 'filed' for SEC liability purposes.

11-06-2026

CoreWeave, Inc. announced on June 11, 2026, its intention to offer $3.5 billion (or euro equivalents) in aggregate principal amount of senior notes due 2032 in a private offering. The proceeds will be used for general corporate purposes, including repayment of outstanding indebtedness and payment of fees and expenses. The offering is subject to market and other customary conditions, and there is no guarantee it will be completed on favorable terms or at all.

• · The notes will be general senior unsecured obligations guaranteed on a senior unsecured basis by certain wholly-owned subsidiaries.
• · The offering is private, targeting qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S.
• · The company filed a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) as part of the 8-K.
• · The information in Item 7.01 is furnished, not filed, for SEC purposes.

11-06-2026

Pelican Acquisition II Corp, a newly formed blank check company, filed a registration statement on Form S-1 with the SEC on June 10, 2026 for an IPO of up to 7,500,000 units (or 8,625,000 if the over-allotment option is exercised in full) at $10.00 per unit, with each unit consisting of one ordinary share and one right. The offering is on a firm commitment basis with EarlyBirdCapital, Inc. as the sole book-running manager. The company intends to focus on technology businesses globally, but has not identified any specific target. Upon consummation, $10.10 per unit will be deposited into a trust account. Key risks include immediate and substantial dilution for public shareholders, as the sponsor acquired founder shares at a nominal price, and the company's management may have conflicts of interest in selecting a target. The registration statement highlights that investors will not be entitled to protections normally afforded to investors in Rule 419 blank check offerings.

• · The company is a blank check company incorporated in the Cayman Islands on February 26, 2026.
• · The company will qualify as an 'emerging growth company' under the JOBS Act and will be subject to reduced reporting requirements.
• · The offering is structured as a firm commitment underwriting.
• · The securities are expected to be listed on Nasdaq under symbols 'PLCI' (ordinary shares) and 'PLCIR' (rights).
• · The trust account will be maintained by Continental Stock Transfer & Trust Company.
• · The underwriter (EarlyBirdCapital, Inc.) will receive 200,000 EBC founder shares as additional compensation.
• · Upon 100% redemption of public shares and assuming no over-allotment, the net tangible book value per ordinary share is $0.29, representing a difference of $9.71 from the offering price.
• · The sponsor acquired founder shares at a nominal price, which will result in immediate and substantial dilution for public shareholders.
• · There is a potential conflict of interest as management may have fiduciary duties to other entities that could affect target selection.
• · No specific business combination target has been identified, and no substantive discussions have occurred.
• · The company's management team includes Robert Labbe, who has prior SPAC experience with Pelican Acquisition Corporation (which merged with Greenland Exploration Limited).
• · Working capital loans of up to $1,500,000 may be converted into private units at $10.00 per unit.
• · The company's initial business combination must be with a target having a fair market value of at least 80% of the trust account balance.

11-06-2026

Black Hawk Acquisition Corp is pursuing a business combination with Vesicor Therapeutics, an early-stage biopharmaceutical company developing an ecm-RV/p53 product candidate in preclinical planning. The SPAC has experienced significant shareholder redemptions of 69.2% (4,775,923 public shares), leaving approximately $22.7 million in trust, and faces a Nasdaq delisting risk due to market value of listed securities below $50 million. While the sponsor has provided convertible note funding, Vesicor remains pre-revenue with development not expected to commence until Q4 2026.

• · Vesicor is an early development stage biopharmaceutical company with no revenue since inception (April 2008) and has had losses; preclinical/IND studies expected to begin Q4 2026
• · Black Hawk received a Nasdaq MVLS deficiency notice on March 31, 2026, with a compliance deadline of September 28, 2026; needs MVLS ≥ $50M for 10 consecutive business days
• · The sponsor has issued four convertible notes (June 2025, September 2025, February 2026, May 2026) with total principal of $1.3M; all convertible at $1.00 per share
• · The June 2025 note carries a 6% interest rate; the three subsequent notes each carry a 10% interest rate
• · The Extraordinary General Meeting is scheduled to take place in 2026 (specific date blank in filing)
• · As of filing date, Vesicor plans to redomesticate from California to Delaware prior to closing
• · Public shares remain redeemable up to two business days before the initially scheduled EGM date
• · No revenue or operating history for either Black Hawk (blank check company since Sept 2023) or Vesicor (preclinical stage)

11-06-2026

Btab Ecommerce Group, Inc. (OTC: BBTT) announced the launch of its Strategic Alliance Initiative, aiming to activate its network of over 300,000 small and medium businesses as AI-powered commerce partners. The initiative leverages Agentic AI to provide ecommerce storefronts, AI selling tools, supply chain, and fulfillment services, with Btab sharing in the commercial upside. While the company highlights significant long-term potential, it provides no specific financial guidance and cautions that actual results may vary, and the forward-looking statements are subject to numerous risks and uncertainties.

• · The filing is made pursuant to Rule 425 under the Securities Act of 1933 and deemed filed under Rule 14a-12, referencing SEC File No. 333-289035-01, indicating it is related to a pending business combination with IWAC.
• · Btab's network currently attracts millions of monthly visitors from more than 70 countries.
• · The initiative is open to both existing Btab platform users and new entrepreneurs.
• · Manufacturer demand across Asia, the United States, and Europe has been strong, with growing inbound interest from producers.
• · Btab expects to formalize relationships with thousands of manufacturers globally as the initiative scales.
• · The initiative is built entirely on Btab's owned and operated platform infrastructure, including digital commerce platforms, supply chain operations, warehousing capabilities, and ecommerce technologies developed over more than a decade.
• · Btab has identified Agentic AI as a critical enabler for automating supply chain coordination, partner onboarding, ecommerce operations, and customer engagement at scale.

11-06-2026

Hooker Furnishings reported net income of $1.1M ($0.10 per share) for Q1 FY2027, a $4.1M improvement from a net loss in the prior-year period, driven by a $17.5M reduction in fixed costs and a 440 bps gross margin expansion. However, consolidated net sales declined 2.4% to an undisclosed absolute amount, with Hooker Branded sales down 4.8% and Domestic Upholstery posting an operating loss of $689K. The company remains cautious on Q2 due to macroeconomic pressures and expects new tariffs on imported goods later this fiscal year, though retailer commitments to Margaritaville products and a 30% backlog increase provide some optimism.

• · Approximately 70% of Hooker Branded net sales decrease was attributed to the imported upholstery line due to inventory constraints, supply chain delays, product mix transitions and softer retail demand.
• · Domestic Upholstery recorded an operating loss of $689K, driven primarily by its indoor residential furnishings businesses.
• · The company did not recognize any receivable or cost reduction related to potential tariff refunds due to uncertainty; it is applying a gain contingency model under U.S. GAAP.
• · No outstanding term loan balance and no outstanding balance on the credit facility as of Q1 end.
• · The share repurchase program began on April 21, 2026, with a 90-day waiting period before first purchases; 7,615 shares were repurchased at an average price of $12.53.
• · The company expects certain tariffs to be levied on imported goods later this fiscal year, replacing at least in part the tariffs overturned by the U.S. Supreme Court.
• · Consolidated incoming orders increased 8% in May vs prior year, and backlog was up 14% year-over-year, driven primarily by Margaritaville orders.
• · Retailer commitments to Margaritaville have grown to 100 in-store galleries and 10 free-standing stores, compared to about half those numbers when reported in December.

11-06-2026

Copley Acquisition Corp (NYSE: COPL) announced a definitive business combination agreement with Ignite Proteomics, a leader in pathway-level protein analytics for precision oncology. The combined entity will be named Ignite Proteomics Holdings, Inc. and will list on the NYSE at a pro forma enterprise value of $150 million. The transaction is expected to close in the second half of 2026, subject to customary conditions and shareholder approvals.

• · Copley is a SPAC that went public via an IPO on December 19, 2023.
• · Ignite's current commercial focus is in breast cancer, with plans to expand into other tumor types.
• · Clear Street LLC acted as financial advisor to Copley; Ladenburg Thalmann & Co. Inc. acted as financial advisor to Ignite.
• · The transaction is subject to adoption by Copley shareholders and Ignite members, as well as other customary closing conditions.

11-06-2026

Prologis Yen Finance LLC (a subsidiary of Prologis, L.P.) priced and expects to close a ¥44.9 billion (¥44.9B) three-tranche yen-denominated senior unsecured note offering on June 11, 2026, comprising ¥32.6B of 2.527% Notes due 2030, ¥3.5B of 3.389% Notes due 2035, and ¥8.9B of 3.905% Notes due 2041. Net proceeds of approximately ¥44.7B ($280.6M based on a May 22, 2026 exchange rate) will be used to repay borrowings under the Operating Partnership's Japanese yen revolving credit facility and for general corporate purposes. The notes are issued under a base indenture dated September 25, 2018, and the program registration statement (File No. 333-289636).

• · The notes are senior unsecured obligations of the Issuer and fully and unconditionally guaranteed by Prologis, L.P.
• · The Indenture includes restrictions on the Operating Partnership's and its subsidiaries' ability to incur additional indebtedness and to merge or consolidate.
• · The notes are redeemable at par plus accrued interest only in the period shortly before maturity (one month for 2030 Notes, three months for 2035 and 2041 Notes) or in the event of certain tax law changes affecting the U.S.
• · The Issuer may redeem the notes in whole (but not in part) upon certain U.S. tax law developments.
• · The offering was made under the Registration Statement (File No. 333-289636) and a prospectus supplement dated June 4, 2026.

11-06-2026

General Fusion Inc., ranked #1 on TIME's 2026 World's Top GreenTech Companies list, is advancing its proposed business combination with Spring Valley Acquisition Corp. III (NASDAQ: SVAC) valued at ~$1 billion. The company's Lawson Machine 26 (LM26), a Magnetized Target Fusion demonstration machine at 50% commercial-scale diameter, is already in operation pursuing key technical milestones. The filing is a paid promotional article, and the proposed transaction remains subject to regulatory review and shareholder approval.

• · General Fusion selected from 8,300+ applicants for TIME ranking
• · LM26 mechanically compresses plasma with a lithium liner at 50% commercial-scale diameter
• · Technical milestones: plasma heating to 1 keV, then 10 keV, ultimately Lawson criterion for net fusion energy
• · LM26 designed, built, and began operation in under two years
• · Company founded in 2002, headquartered in Vancouver, Canada
• · SVAC will continue from Cayman Islands to British Columbia as part of the transaction
• · Post-combination company will be named 'General Fusion Group Ltd.' and expected to list on Nasdaq under ticker GFUZ
• · This article is paid promotional content from USA News Group / Market IQ Media Group, compensated by Creative Direct Marketing Group

11-06-2026

Tilly's, Inc. held its 2026 annual meeting on June 10, 2026, where stockholders elected seven directors, approved the Fourth Amendment and Restated 2012 Equity and Incentive Award Plan, ratified BDO USA, P.C. as independent auditor, and approved executive compensation on an advisory basis. All proposals passed with strong support, though broker non-votes were significant on most items.

• · All seven director nominees were elected with votes for ranging from 77,128,473 to 77,326,500, and votes withheld from 2,633,871 to 2,831,898.
• · Proposal 2 (Plan approval) received 79,220,610 votes for, 739,201 against, and 560 abstentions.
• · Proposal 3 (auditor ratification) passed with 86,460,798 votes for, 196,042 against, and 8,281 abstentions, with no broker non-votes.
• · Proposal 4 (advisory say-on-pay) received 78,298,527 votes for, 1,263,128 against, and 398,716 abstentions.
• · Broker non-votes were 6,704,750 on Proposals 1, 2, and 4, but zero on Proposal 3.

11-06-2026

PureCycle Technologies announced concurrent public offerings of $250.0M in convertible senior notes due 2032 and $145.0M in common stock, with underwriter over-allotment options of up to $37.5M and $18.75M respectively. The net proceeds will be used to repurchase a portion of its outstanding 7.25% green convertible notes due 2030, for working capital, and general corporate purposes. The offerings are subject to market conditions and there is no assurance of completion.

• · The notes will be general unsecured obligations and accrue interest semiannually in arrears; interest rate and conversion rate to be determined at pricing.
• · PureCycle intends to repurchase a portion of its outstanding 7.25% green convertible notes due 2030 using proceeds from the offerings.
• · The offerings are made under an automatically effective shelf registration statement on Form S-3 (File No. 333-296672) filed June 10, 2026.
• · Morgan Stanley is the sole bookrunner for both offerings.
• · PureCycle holds a global license for patented dissolution recycling technology developed by P&G to transform polypropylene plastic waste (#5 plastic) into PureFive® resin.

11-06-2026

Seer, Inc. distributed a DEFA14A filing on June 11, 2026, containing an email to employees urging them to vote using the company's BLUE proxy card in support of its seven director nominees at the upcoming Annual Meeting. The filing warns that two stockholders, Bradley Radoff and Michael Torok, are soliciting votes for their own nominees via a white proxy card, which Seer's Board does not endorse. The Board unanimously recommends voting 'FOR' Seer's nominees, and employees who already voted using the white card can change their vote.

• · The filing is Definitive Additional Materials (DEFA14A) filed on June 10, 2026.
• · Stockholders Bradley Radoff and Michael Torok are soliciting votes for their own nominees using a white proxy card.
• · Seer's Board unanimously recommends voting 'FOR' each of its seven director nominees.
• · Employees who already voted using the white card can change their vote by voting again via the Internet or telephone using the BLUE proxy card.
• · Innisfree M&A Incorporated is the proxy solicitation firm, reachable at (877) 456-3524.

11-06-2026

Olenox Industries Inc. (formerly Safe & Green Holdings Corp.) appointed Erik Blum as President effective June 1, 2026, with a one-year employment agreement providing a $200,000 annual base salary, a $50,000 restricted stock grant vesting over 18 months, and an annual performance bonus of up to 20% of base salary. Concurrently, the company dismissed CFO Patricia Kaelin on June 5, 2026, and has begun searching for a replacement. The filing does not disclose any financial results or period-over-period comparisons.

• · Erik Blum has over 30 years of experience in debt, corporate finance, and company management, and previously led FYNN from non-reporting pink sheet status to an audited reporting entity as of November 2023.
• · Blum resigned from the Audit Committee and as Chair of the Audit Committee prior to his appointment as President.
• · Blum is subject to a one-year post-termination non-compete and non-solicit, and confidentiality provisions.
• · Patricia Kaelin was dismissed on June 5, 2026, and the company received her resignation letter the same day.
• · The company will file any response letter from Kaelin with the SEC within two business days of receipt.

11-06-2026

ONE Nuclear Energy, a baseload power platform combining natural gas generation with advanced nuclear SMRs, is going public via a merger with Hennessy Capital Investment Corp. VII (HVIIU) and a parallel PIPE process. The company targets behind-the-meter gas power by 2028, one gigawatt online by end of 2029, and up to 15 gigawatts of combined gas and nuclear capacity by 2033. However, the nuclear SMRs are not expected until the 2030s, and the company faces significant execution risk with a multi-site development pipeline of over 75 sites but only three in active development.

• · Gas engines cost under $1,000/kW vs. ~$3,000/kW for large turbines, a 67% lower overnight capex.
• · Gas engines require only ~8% redundancy vs. 50-65% for large turbines, a massive capex difference.
• · Revenue is locked in via 15-year inflation-linked PPAs with single-A+ rated counterparties; gas commodity costs are passed through, so no commodity exposure.
• · EBITDA margins close to 50%.
• · Three active development sites: East Texas (1,600 acres, targeting 1 GW gas by 2029, 2 GW nuclear by 2034, up to 6 GW total), New Mexico (6,000 acres, exclusive developer for initial 1 GW with phased expansion to 10 GW, PPAs/FID expected 2027), Washington (7,200 acres, up to 6 GW SMR capacity).
• · Nuclear SMRs not expected until the 2030s; near-term focus is on gas power by 2028.
• · Grid interconnection backlog averages more than four years, driving behind-the-meter strategy.
• · Battery storage sized at roughly 30% of generation capacity as a rule of thumb for three-nines reliability.
• · Advisory board includes political, regulatory, nuclear, and insurance experts.
• · Independent directors include Kyle Crowley (30 years at Exelon/Constellation) and Darryl Willis (Microsoft Corporate VP).

11-06-2026

Perceptive Capital Solutions Corp (PCSC) filed an S-4/A registration statement on June 10, 2026, detailing its proposed business combination with Freenome Holdings, Inc. The transaction involves a domestication from Cayman Islands to Delaware, a name change to Freenome, Inc., and a PIPE financing of $240.0 million (24,000,000 shares at $10.00 per share). However, the filing also reveals that 754,008 Class A ordinary shares were redeemed for approximately $8.2 million in connection with an extension amendment, reducing trust account proceeds to approximately $85.2 million, and that public shareholders will experience immediate dilution post-combination, with their ownership dropping from 76.3% to an estimated 1.90% under the maximum redemption scenario.

• · The Business Combination Agreement was approved by PCSC Board on December 4, 2025 and dated December 5, 2025.
• · The Domestication will change PCSC's jurisdiction from Cayman Islands to Delaware, and rename the entity to Freenome, Inc.
• · The PIPE Financing is conditioned on Nasdaq listing of New Freenome Common Stock and satisfaction of all conditions precedent in the Business Combination Agreement.
• · The Extension Amendment extended the deadline for PCSC to complete its initial business combination from June 13, 2026 to June 13, 2027.
• · Under the maximum redemption scenario, public shareholders' ownership drops from 76.3% to 1.90%, indicating significant dilution.
• · The Sponsor will own 2.20% post-combination, including 2,156,250 Class B Shares and 286,250 private placement shares.
• · Roche will own approximately 18.11% of New Freenome Common Stock post-combination.

11-06-2026

Presidio Production Company announced the closing of a $350 million investment-grade ABS refinancing that reduces its weighted-average coupon by 184 bps (from 8.22% to 6.38%) and lowers scheduled amortization, enhancing free cash flow for dividends. The proceeds were used to refinance prior ABS debt, pay down $37 million drawn under its RBL, add $35 million of hedges, and pay expenses; the RBL remains undrawn with a $65 million borrowing base. The press release does not include any negative metrics or flat performance, but the overall sentiment is positive due to lower cost of capital and improved liquidity.

• · The ABS was issued with a master trust and first-of-its-kind oil and gas ABS make-whole provisions.
• · The ABS is redeemable at the Company's option at 102% prior to year 1, 101% prior to year 2, and 100% (par) thereafter.
• · Hedging program details: Oil swaps volume from 274 MBbl (2Q26) to 933 MBbl (Beyond); Natural gas swaps from 6,264 BBtu (2Q26) to 47,417 BBtu (Beyond); Natural gas basis swaps from 5,990 BBtu (2Q26) to 0 (Beyond); NGL swaps from 556 MBbl (2Q26) to 1,316 MBbl (Beyond).
• · Strike prices for oil swaps range from $57.35/Bbl (2Q26) to $108.29/Bbl (2Q27).
• · Strike prices for natural gas swaps range from $6.23/MMBtu (2Q26) to $3.49/MMBtu (Beyond).
• · Previous ABS debt (including accrued interest and make-whole fees) paid off with $263 million of proceeds.
• · RBL borrowing base of $65 million remains undrawn after the $37 million pay down.

11-06-2026

Inflection Point Acquisition Corp. VI (IPFX) is pursuing a business combination with Quantum Space, a high-energy spacecraft company focused on national security space capabilities. CEO Jim Bridenstine highlighted the U.S. Space Force budget doubling to $71 billion, driving demand for the company's sustained maneuver spacecraft. The deal aims to provide public market capital for rapid scaling, including large-scale manufacturing in Tulsa, Oklahoma, though the flagship vehicle 'Ranger' remains in development with no sales to date.

• · Quantum Space is taking the company public via a SPAC merger with Inflection Point Acquisition Corp. VI.
• · The company plans to scale manufacturing from building 1-2 satellites at a time to dozens, then hundreds, with a facility in Tulsa, Oklahoma.
• · Quantum Space's spacecraft is designed for 'sustained maneuver' with refuelable and modular architecture, targeting a 15-year operational life.
• · The business combination is subject to shareholder approval and regulatory filings, including a Registration Statement with the SEC.
• · Risk factors include the inability to complete development of the Ranger vehicle, which has not been manufactured, operated, or sold to date.

11-06-2026

On June 10, 2026, Kennedy-Wilson Holdings, Inc. held its 2026 Annual Meeting of Stockholders where all six proposals presented were approved. Notably, stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm and approved, on a non-binding advisory basis, the compensation of named executive officers. The meeting also saw significant shareholder engagement with over 97% of outstanding shares voted.

• · Proposal 1 (Election of Directors): all four nominees (Mary E. Bandecon, Michael J. O’Gara, William R. Sheridan) were elected with at least 94.9 million votes for each; no nominee received more than 15.3 million withheld votes.
• · Proposal 3 (Ratification of Auditor): 150,189,326 votes for (97.6%), 3,698,543 against, and 6,003,813 abstentions.
• · Proposal 2 (Advisory Compensation): 139,652,324 votes for (90.6%), 14,461,868 against, 5,773,490 abstentions.
• · Proposal 4 (Advisory Frequency of Say-on-Pay): 148,117,506 votes for every year (97.3%), 3,024,471 for every 2 years, 368,455 for every 3 years, and 380,350 abstentions.
• · Proposal 5 (Stockholder Proposal: Lobbying Report): 65,452,587 votes against (55.3%), 52,903,483 for, and 19,530,732 abstentions.
• · Proposal 6 (Stockholder Proposal: Independent Board Chair): 64,292,709 votes against (54.4%), 53,905,403 for, and 19,688,210 abstentions.

11-06-2026

Myseum.AI, Inc. announced its sponsorship and panel participation at the Visual 1st 2026 conference (Sept 29–30, San Francisco) and disclosed development of privacy-first agentic-localized AI agents for personal media management. The company's CEO will speak on a panel about its Picture Party platform, which enables encrypted galleries and controlled sharing. No financial metrics or period-over-period comparisons were provided in this filing.

• · Visual 1st 2026 conference takes place September 29–30 in San Francisco, CA.
• · CEO Darin Myman will speak on a panel titled 'Visuals for Connection — Transforming shared media into social glue.'
• · Picture Party is currently available on iOS App Store and Google Play, with a desktop version expected later this year.
• · The company was formerly known as DatChat Inc. and changed its name to Myseum.AI, Inc. on August 7, 2025.
• · Series A Warrants (MYSEW) are exercisable for one share of Common Stock at an exercise price of $49.80.

11-06-2026

Smith-Midland Corporation filed an 8-K on June 10, 2026, to furnish presentation materials (Exhibit 99.1) for use in discussions with investors, lenders, and other stakeholders. The presentation contains forward-looking statements and is dated as of June 10, 2026. No specific financial figures or performance metrics were disclosed in the filing itself.

• · The presentation materials are furnished under Item 7.01 Regulation FD Disclosure and are not deemed filed for Section 18 purposes.
• · The company disclaims any obligation to update the presentation materials after the filing date.
• · Forward-looking statements are subject to risks detailed in the company's 2025 Form 10-K and subsequent quarterly reports.

11-06-2026

Silvina Moschini resigned as Chief Strategy Officer of Unicoin Inc., effective June 1, 2026, to become Interim CEO of the Unicoin Foundation. The filing highlights a positive regulatory outlook and the company's planned ICO, but no financial metrics or performance data are provided.

• · Resignation effective June 1, 2026.
• · Moschini transitions to Interim CEO of the Unicoin Foundation.
• · Filing references a more constructive regulatory environment and new crypto taxonomy as opportunities.
• · No financial figures, employee counts, or performance metrics are disclosed in this filing.

11-06-2026

Sentinel Holdings Ltd. (SNTL) dismissed its independent auditor, Bush & Associates CPA LLC, on June 10, 2026, and appointed DiPiazza LaRocca Heeter & Co., LLC (DLHC) as its new auditor for fiscal year 2026. The dismissal followed the completion of the 2025 audit, and the prior audit reports (2025 and 2024) contained a going concern qualification but no adverse opinions or disagreements. No reportable events or disagreements occurred during the prior audits, and DLHC was not consulted on any accounting matters before engagement.

• · The company's common stock trades on the OTCMKTS under the symbol SNTL.
• · The new auditor, DLHC, is based in Birmingham, AL, and will begin with the review of the March 31, 2026 quarterly financial statements.
• · The company is not an emerging growth company and has not elected the extended transition period for new accounting standards.
• · The prior auditor's reports for fiscal years 2024 and 2025 each contained a going concern qualification.

11-06-2026

GameStop Corp. has proposed to acquire all outstanding shares of eBay Inc. not already owned at $125 per share in a cash-and-stock deal. As of the filing, GameStop beneficially owns 2,480,467 eBay shares directly and has economic exposure to an additional 39,046,658 shares through put/call option pairs, which became physically settleable after HSR Act conditions were satisfied on June 3, 2026. The proposal is non-binding and subject to negotiation, regulatory approvals, and shareholder approvals, with no definitive agreement yet reached.

• · The put/call option pairs expire February 23, 2028, and were only cash-settleable until the HSR Act Condition was satisfied on June 3, 2026.
• · GameStop does not have voting or dispositive power over the option shares unless physically settled.
• · The proposal was delivered to eBay's board on May 3, 2026, and is non-binding.
• · GameStop has not had access to eBay's books and records.
• · The filing includes a repost by Ryan Cohen on X (June 10, 2026) with an empty post, which triggered the 425 filing.

11-06-2026

Modiv Industrial, Inc. declared a quarterly dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock for Q2 2026, payable July 15, 2026 to holders of record as of June 30, 2026. The company also declared monthly distributions of $0.10 per share on its Class C common stock for July and August 2026, equivalent to an annualized rate of $1.20 per share. The filing notes there is no guarantee of future dividends, as they depend on the Board's assessment of financial condition and other factors.

• · The Series A Preferred Stock dividend record date is June 30, 2026, and payment date is July 15, 2026.
• · The July Common Stock distribution record date is July 31, 2026, payable on or about August 10, 2026.
• · The August Common Stock distribution record date is August 3, 2026, payable on or about August 10, 2026.
• · The Board authorized the Common Stock distributions on June 10, 2026.
• · The Board authorized the Series A Preferred Stock dividend on May 7, 2026.

11-06-2026

Kiora Pharmaceuticals held its 2026 Annual Meeting on June 10, 2026, where shareholders elected three Class II directors (Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle, Ph.D.) and approved an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 1,500,000. All proposals received majority support, though broker non-votes on several items were significant, and the equity plan amendment garnered the lowest approval rate among voted shares (approximately 69% for vs. 29% against). The ratification of Haskell & White LLP as independent auditor was overwhelmingly approved with over 99.7% of votes cast in favor.

• · Broker non-votes totaled 1,320,660 on Proposals 1, 2, and 4, representing about 48% of the outstanding shares.
• · Lisa Walters-Hoffert received the most votes for among directors with 1,037,950 (99.26% of votes cast excluding broker non-votes).
• · Praveen Tyle, Ph.D. received the fewest votes for among directors with 1,029,403 (98.45% of votes cast excluding broker non-votes).
• · Proposal 3 (auditor ratification) had no broker non-votes and passed with overwhelming support.

11-06-2026

Hycroft Mining Holding Corp. entered into an employment agreement with Eric B. Colby as Executive Vice President, Corporate Development and Investor Relations, effective June 8, 2026. Mr. Colby brings extensive mining and capital markets experience, including 15 years at Newmont Corporation and most recently as VP Operations at Magris Performance Materials. The agreement provides a base salary of $450,000, an annual cash incentive bonus target of 80% of base salary (0%-200% range), and includes standard termination and change-in-control provisions.

• · Mr. Colby joined Hycroft in April 2026, prior to the formal employment agreement.
• · Termination without Cause or for Good Reason entitles Mr. Colby to 1.5x base salary paid over 18 months plus 18 months of continued benefits.
• · Termination after a Change in Control (within 90 days before or 1 year after) entitles Mr. Colby to 2.0x base salary plus 2.0x the greater of prior year actual bonus, current year actual bonus, or target bonus, paid in a lump sum on day 60, plus 24 months of continued benefits.
• · The agreement includes standard definitions for Cause, Change in Control, Disability, and Good Reason.
• · Mr. Colby is an at-will employee and may be terminated at any time for any or no reason.

11-06-2026

PetVivo Holdings received $150,000 in gross proceeds from a partial exercise of an investor's purchase option under a Subscription Agreement dated March 13, 2026, bringing total aggregate investment to $1,150,000. The company issued 187,500 Units at $0.80 per Unit, each consisting of one common share and one warrant exercisable at $1.10 per share for three years. While the company has raised a meaningful cumulative amount, the current tranche of $150,000 is relatively modest, and the weighted average price of $0.80 per Unit is well below the warrant exercise price of $1.10, implying limited near-term upside for the warrants.

• · The Offering is conducted under the exemption from registration under Section 4(a)(2) of the Securities Act and Regulation D; the investor is an accredited investor.
• · The Securities issued (shares, warrants, and underlying shares) are restricted securities under Rule 144 and bear a restrictive legend.
• · The investor's remaining purchase option is exercisable through July 15, 2026.
• · The warrants have a three-year expiration from the date of issuance.
• · Common stock trades on OTCQX under symbol PETV; warrants trade on OTCID under symbol PETVW.

11-06-2026

West Enclave Merger Corp. (WENC) filed its 10-Q for the quarter ended March 31, 2026, reporting a net loss of $40,398 and negative cash flow from operations of $26,973. The company had total assets of $658,947, primarily deferred offering costs, and total liabilities of $295,825, with shareholders' equity of $363,122. While the company raised $71,375 through a related-party promissory note and $1,630 from EBC shares, it remains in a pre-revenue stage with no operating income.

• · The company had no revenue and a net loss of $40,398 for the quarter.
• · Cash used in operating activities was $26,973.
• · Deferred offering costs increased from $439,470 to $647,810, reflecting ongoing IPO-related expenses.
• · Accrued offering costs rose sharply from $44,850 to $216,720.
• · The promissory note from a related party increased from $2,420 to $73,795, indicating additional borrowing.
• · Shareholders' equity decreased from $401,890 to $363,122 due to the net loss.
• · The subscription receivable was fully collected ($1,630) during the quarter.
• · Basic and diluted net loss per share was $(0.01).

11-06-2026

Kardigan, Inc. filed an S-1/A registration statement for an IPO of 23,333,334 shares of voting common stock at an assumed price of $15.00 per share, with net proceeds estimated at $320.3 million. The net loss increased sharply to $56.1 million in Q1 2026 from $18.0 million in Q1 2025, and full-year 2025 net loss was $191.9 million versus $88.7 million in 2024, reflecting rapidly escalating R&D and G&A expenses. The company will use proceeds to fund clinical development of Danicamtiv, Ataciguat, and Tonlamarsen.

• · The net loss per share (basic and diluted) for Q1 2026 was $3.86, compared to $1.54 in Q1 2025; for FY 2025 it was $14.84 vs $8.79 in FY 2024.
• · Pro forma net loss per share (basic and diluted) for Q1 2026 is $0.90, and for Q1 2025 is $3.20, reflecting conversion of preferred stock into common shares.
• · Pro forma weighted-average shares outstanding for Q1 2026 is 62,301,214; for Q1 2025 is 59,955,414.
• · The company conducted a 1.5928-to-one stock split on June 9, 2026.
• · As of March 31, 2026, total assets were $348.2 million (actual) and pro forma as adjusted $668.5 million.
• · Working capital as of March 31, 2026: actual $266.5 million; pro forma as adjusted $588.0 million.
• · Total liabilities as of March 31, 2026: $51.3 million (actual, pro forma, and pro forma as adjusted).
• · Redeemable convertible preferred stock of $597.5 million is converted to zero on a pro forma basis.
• · The assumed IPO price of $15.00 per share is the midpoint of the estimated price range on the cover page.
• · The underwriters' option is exercisable for 30 days from the date of the prospectus.
• · No non-voting common stock will be outstanding immediately after the offering; conversion of non-voting shares is limited to prevent beneficial ownership above 9.99%.

11-06-2026

Shoe Carnival, Inc. (SCVL) announced shareholder approval to change its corporate name to Shoe Station Group, Inc., effective June 12, 2026, with its Nasdaq ticker symbol changing from SCVL to SHOE on the same date. The company also declared a quarterly cash dividend of $0.17 per share, payable July 20, 2026, marking its 57th consecutive quarterly dividend. The name change reflects a multi-banner strategy with Shoe Station as the primary long-term growth vehicle, while Shoe Carnival continues in markets where it is dominant, and the company plans to pursue strategic acquisitions of other footwear retailers.

• · The name change and ticker change are effective June 12, 2026; shares trade under SCVL through June 11, 2026.
• · CUSIP number remains unchanged at 824889109.
• · Transfer agent is Computershare.
• · The company operated 426 stores in 35 states and Puerto Rico as of June 11, 2026.
• · Dividend record date is July 6, 2026; payment date is July 20, 2026.
• · Future dividends are subject to Board approval and depend on results of operations, financial condition, and business conditions.

11-06-2026

Terra Property Trust disclosed cash flow projections for April-September 2026, expecting aggregate cash inflows of approximately $47.1 million and outflows of $51.9 million (assuming partial exchange offer participation) or $37.9 million (assuming full participation). The company also extended its exchange offer for its 6.00% Senior Notes due June 30, 2026, offering new 11.00% Senior Secured Notes due July 1, 2027 plus cash. While the company anticipates significant inflows from asset monetizations, the projected cash shortfall under the partial participation scenario highlights ongoing liquidity pressure.

• · The exchange offer was extended on June 11, 2026, as announced in a press release (Exhibit 99.1).
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
• · Projected cash outflows include approximately $1.6 million for capital contributions to an equity investment and the remainder for scheduled debt service, operating expenses, and other corporate expenditures.
• · Projected cash inflows include approximately $5.7 million from partial repayment of a mezzanine loan secured by an infill land property expected in June 2026.
• · The company's securities registered under Section 12(b) are the 6.00% Notes due 2026, trading under symbol TPTA on the NYSE.

11-06-2026

Samfine Creation Holdings Group Ltd, a Hong Kong-based commercial printing company, filed an F-1 registration statement with the SEC on June 10, 2026, for an initial public offering of Class A ordinary shares. The company highlights significant risks related to its operations in Hong Kong and the PRC, including regulatory uncertainties, reliance on dividends from subsidiaries, and lack of long-term customer contracts. The offering is on a best-efforts basis with no minimum amount required, and the company is subject to less stringent disclosure requirements as a foreign private issuer.

• · The company's principal executive office is at Flat B, 8/F, Block 4, Kwun Tong Industrial Centre, 436-446 Kwun Tong Road, Kwun Tong, Kowloon, Hong Kong.
• · The company is incorporated in the Cayman Islands and its registered office is at Osiris International Cayman Limited, Suite #4-210, Governors Square, 23 Lime Tree Bay Avenue, PO Box 32311, Grand Cayman KY1-1209, Cayman Islands.
• · The company's website is http://www.1398.cn/.
• · The company is a 'controlled company' under Nasdaq rules and may follow exemptions from certain corporate governance requirements.
• · The company is not required to obtain approval from Hong Kong authorities for this offering, but is subject to CSRC filing requirements under the Trial Measures.
• · The company is not currently subject to cybersecurity review by the CAC as it does not operate a network platform for individual users and has less than 1 million users of personal information.
• · The offering is on a best-efforts basis with no minimum number or dollar amount of securities required to be sold.

11-06-2026

GE Aerospace announced the appointment of Judson Althoff, CEO of Microsoft’s Commercial Business, to its Board of Directors, effective June 24, 2026. Althoff brings deep experience in AI transformation and commercial strategy, which will support the company's FLIGHT DECK initiative and AI expansion. The filing contains no financial results or negative/declining metrics.

• · Judson Althoff has nearly a decade of experience as chief architect of Microsoft’s commercial strategy.
• · Althoff joined Microsoft in March 2013 as President of Microsoft North America.
• · He previously held senior sales roles at Oracle and EMC.
• · Althoff is a graduate of the Illinois Institute of Technology (IIT).
• · He serves on the board of Ecolab as an independent director and on its Safety, Health & Environment and Finance Committees.
• · GE Aerospace has an installed base of approximately 50,000 commercial and 30,000 military aircraft engines.
• · The company employs approximately 57,000 people globally.

11-06-2026

Compass Diversified (CODI) announced that CEO and co-founder Elias Sabo will retire on December 31, 2026, and will be succeeded by Zach Sawtelle, who has been appointed COO and named CEO successor. The company reaffirmed its full-year 2026 outlook with strong subsidiary momentum, while continuing to review its Management Services Agreement to align incentives with shareholders.

• · CEO Elias Sabo will retire as CEO and a director on December 31, 2026.
• · Zach Sawtelle appointed COO effective June 11, 2026, and will succeed Sabo as CEO/Board member upon retirement.
• · Sawtelle joined Compass Group Management in 2009 and led over 20 strategic transactions representing over $3B aggregate value.
• · Sawtelle chairs BOA and held board roles at PrimaLoft, The Honey Pot, 5.11, and Altor Solutions.
• · Company reaffirms previously announced 2026 outlook; expects to complete Management Services Agreement review 'in the coming weeks'.
• · CODI remains focused on reducing leverage, maximizing subsidiary value, and returning capital to shareholders opportunistically.

11-06-2026

Designer Brands Inc. announced a quarterly cash dividend of $0.05 per share on its Class A and Class B common shares, approved by the Board on June 10, 2026. The dividend will be paid on July 8, 2026 to shareholders of record as of June 25, 2026. No prior period dividend data is provided in this filing, so no period-over-period comparison is available.

• · Dividend record date: June 25, 2026
• · Dividend payment date: July 8, 2026
• · Dividend applies to both Class A and Class B common shares

11-06-2026

Dana Incorporated announced a definitive agreement to combine with Eaton's Mobility business in a Reverse Morris Trust transaction valued at approximately $5.1 billion. The combined company is expected to have pro forma 2026 estimated sales of approximately $11 billion and adjusted EBITDA of approximately $1.7 billion (15% margin), with $250 million in run-rate cost synergies targeted within 24 months of closing. Eaton shareholders will own at least 50.1% of the combined entity, while Dana shareholders will own approximately 49.9%.

• · Transaction structured as a Reverse Morris Trust, enabling tax-efficient separation.
• · Dana 2030 targets increased to $14–$15 billion in sales, ~18% adjusted EBITDA margin, and 8%–9% adjusted free cash flow margin.
• · Transaction values Eaton Mobility at approximately 8.3x estimated 2026 pro forma adjusted EBITDA before synergies, or 5.9x including run-rate synergies.
• · Combined company expected to achieve $250 million of run-rate synergies within 24 months following closing.
• · Eaton shareholders will own at least 50.1% of the combined company; Dana shareholders approximately 49.9%.
• · Dana will host a conference call and webcast at 8:30 a.m. ET on June 11, 2026 to discuss the transaction.

11-06-2026

News Corp filed an 8-K on June 11, 2026, reporting disclosures made to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program. The company is authorized to buy back up to $1 billion in aggregate of its Class A and Class B common stock and provides daily ASX disclosures under local rules. The filing includes forward-looking statements about the intent to repurchase shares, subject to market conditions and regulatory factors.

• · The repurchase program is authorized for up to $1 billion in aggregate of Class A and Class B common stock.
• · Disclosures to the ASX are required on a daily basis and are also included in the company's quarterly and annual reports.
• · The company has no obligation to update the forward-looking statements except as required by law.

11-06-2026

Eaton Corporation plc announced a definitive agreement to separate its Mobility segment and combine it with Dana Incorporated in a Reverse Morris Trust transaction. Under the terms, Eaton will receive approximately $1.1 billion in cash, and Eaton shareholders will own at least 50.1% of the combined company's outstanding shares. The transaction is subject to regulatory and shareholder approvals and is expected to close pending customary conditions.

• · The transaction is structured as a Reverse Morris Trust, involving a separation and distribution of the Mobility segment followed by a merger with Dana.
• · The filing includes cautionary notes about forward-looking statements and risks, including the ability to obtain regulatory approvals and realize anticipated synergies.
• · SpinCo may file a Form 10 or Form S-1/S-4 with the SEC, and Eaton may file a Schedule TO for an exchange offer.
• · The transaction is expected to close pending stockholder and regulatory approvals, with no specific timeline provided.

11-06-2026

AMC Entertainment Holdings, Inc. announced on June 11, 2026, that it completed its previously disclosed at-the-market (ATM) equity offering. The filing does not provide any financial details or performance metrics, only confirming the completion of the offering.

• · The press release was issued on June 11, 2026, and is incorporated by reference as Exhibit 99.1.
• · The information is furnished under Item 7.01 (Regulation FD Disclosure) and is not deemed filed for SEC liability purposes.

11-06-2026

Nurix Therapeutics announced updated Phase 1a/1b clinical data for its BTK degrader bexobrutideg (NX-5948) in relapsed/refractory CLL/SLL at EHA2026. The Phase 1a efficacy showed an ORR of 83.0% with median PFS of 22.1 months, while Phase 1b earlier-line cohorts demonstrated ORRs of 92.9% and 84.2% with short follow-up. However, the safety profile included three Grade 5 adverse events (though deemed unrelated to treatment), and the Phase 1a population was heavily pre-treated with a median of four prior lines of therapy.

• · Median prior lines of therapy in Phase 1a: 4 (range 2-12)
• · Median follow-up in Phase 1a: 22.4 months
• · Median PFS in Phase 1a: 22.1 months (95% CI: 14.0 months to Not Reached)
• · Phase 1b Cohort 5 median follow-up: 5.2 months; 18 of 19 patients remained on treatment
• · Phase 1b Cohort 15 median follow-up: 4.9 months; 19 of 20 patients remained on treatment
• · No dose-limiting toxicities were observed
• · Most common TEAEs: purpura/contusion, neutropenia, petechiae, diarrhea, fatigue

11-06-2026

Lovesac Co reported a net loss of $11.1M for Q1 FY26 (13 weeks ended May 3, 2026), widening from a $10.8M loss in the prior-year quarter. Net sales were essentially flat at $138.2M versus $138.4M, with showroom sales slightly up (+0.6%) and internet sales growing 7.1%, but other channel sales declined 36.3%. Operating cash flow improved to -$35.4M from -$41.4M, while cash and equivalents fell sharply to $57.0M from $101.9M at year-end, partly due to $2.4M in share repurchases.

• · Total assets decreased to $501.0M from $534.7M at year-end, driven by a $44.9M drop in cash.
• · Total liabilities fell to $295.4M from $316.0M, primarily due to lower accrued expenses and payroll payable.
• · Stockholders' equity declined to $205.5M from $218.7M, reflecting the net loss and share repurchases.
• · The company had no borrowings on its line of credit as of May 3, 2026.
• · Weighted average diluted shares outstanding decreased to 14.67M from 14.79M YoY due to share repurchases.
• · Operating lease liabilities (current + long-term) totaled $190.9M, with a weighted average remaining lease term of 6.8 years and a discount rate of 5.63%.
• · Capital expenditures were $5.0M in Q1 FY26, down from $8.6M in Q1 FY25.
• · The company paid $20K in cash for taxes and $30K in cash for interest during the quarter.

11-06-2026

Aurora Cannabis Inc. filed its annual report (40-F) for the fiscal year ending March 31, 2026. Audit fees increased slightly to $4,782,558 from $4,658,658 in the prior year, while tax fees rose sharply to $263,113 from $10,250. Other fees of $56,000 were incurred in FY2026, compared to none in FY2025.

• · No audit-related fees were reported for either fiscal year.
• · All other fees of $56,000 were incurred in FY2026, compared to none in FY2025.

11-06-2026

C4 Therapeutics issued a press release and posted a corporate presentation and a Phase 1 poster for cemsidomide (IKZF1/3 degrader) + dexamethasone in relapsed/refractory multiple myeloma (RRMM) at the EHA 2026 Congress on June 11, 2026. The Phase 1 trial is fully enrolled, but no specific efficacy or safety data from the presentation is disclosed in this 8-K filing. The filing provides no financial updates or period-over-period comparisons.

• · Phase 1 trial of cemsidomide in combination with dexamethasone in RRMM is fully enrolled.
• · Data presented at EHA 2026 Congress; poster and press release are filed as Exhibits 99.2 and 99.3.
• · Corporate presentation posted to investor relations website (Exhibit 99.1).
• · No financial results, capital changes, or material agreements were announced.

11-06-2026

Alithya Group inc. filed its annual report (40-F) for the fiscal year ended March 31, 2026, reporting total revenues of CAD 127,000 Crore (approximately $1.5B). The company completed the acquisition of EVerge Interests Inc. in May 2025 and Medivra Holdings LLC in March 2026, expanding its service offerings. However, the filing also reveals a net loss position and significant long-term debt, indicating ongoing financial challenges alongside growth initiatives.

• · The company has multiple operating segments: Enterprise Performance Management, Enterprise Resource Planning (US), Enterprise Resource Planning (Canada), and Industry Solutions.
• · Alithya has a Senior Secured Revolving Credit Facility with interest rates ranging from Canadian/US Prime Rate to Bankers' Acceptances or LIBOR rates.
• · The company has subordinated unsecured loans with two tranches, with interest rates ranging from bottom to top of range as of November 1, 2025.
• · Deferred tax assets include losses available for carryforward and other tax deductions, lease liabilities, and deferred financing costs.
• · Deferred tax liabilities include intangible assets and goodwill, other deferred tax liabilities, and right-of-use assets.
• · The company has multiple classes of shares: Class A Shares, Class B Shares, Subordinate Voting Shares, Multiple Voting Shares, Series A Preferred Shares, and Series B Preferred Shares.
• · Share-based compensation includes Deferred Share Units (DSUs), Restricted Share Units (RSUs), Performance Share Units (PSUs), and share options.
• · The company has operations in Canada, the United States, France, Morocco, India, and the United Kingdom.
• · Goodwill and intangible assets are significant, with customer-related intangible assets, computer software, brand names, and non-competition agreements.
• · The company has purchase price payables maturing on July 1, 2025, December 1, 2027, and May 31, 2027.

11-06-2026

Orthofix Medical Inc. held its 2026 Annual Meeting of Shareholders on June 10, 2026, where all director nominees were elected, executive compensation was approved on an advisory basis, Ernst & Young LLP was ratified as independent auditor, and shareholders approved Amendment No. 5 to the Stock Purchase Plan, increasing available shares by 1,250,000. While the advisory vote on executive compensation passed, it received significant opposition with 5,577,200 votes against (18.5% of votes cast), indicating notable shareholder dissent.

• · Director Michael E. Paolucci received the highest number of votes against among all nominees (5,367,249), representing 17.8% of votes cast.
• · Director Wayne Burris also faced notable opposition with 5,162,812 votes against (17.2% of votes cast).
• · The advisory vote on executive compensation had 14,545 abstentions in addition to the 5,577,200 against.
• · Auditor ratification passed overwhelmingly with 33,262,505 votes in favor (96.0% of votes cast).
• · The Stock Purchase Plan amendment was approved with 29,235,005 votes in favor (97.2% of votes cast on the matter).